75 articles
Doug Manion’s current work developing cancer therapeutics has been uniquely informed by his connections to family and friends who have suffered from t...
Doug Manion, CEO of Kleo Pharmaceuticals, discusses his personal journey from working as an engineer in Africa to going to med school and then moving in...
Kleo Pharmaceuticals is a unique immuno-oncology company poised to solve some of the problems dominating the headlines for the biopharmaceutical industry.
Dawn Marie Stull PharmD., BCOP scientific director and lead of INSIGHT MM at Takeda Oncology, discusses the INSIGHT MM (multiple myeloma) study, the lar...
Crystal talks about why the opioid crisis has become a fentanyl crisis and an antidote to protect against a fentanyl attack.
Cutler discusses the scientific basis for the host of side effects that can accompany current antipsychotics for treating schizophrenia.
Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the No...
Yutaka Niihara, CEO of Emmaus Life Sciences, discusses Sickle Cell Disease in underserved minority populations and his passion for finding a treatment.
Eric Snyder from Geneticure discusses their recently presented data on a study utilizing their algorithm which can predict which hypertension drug would...
David Arthur, CEO of Salarius Pharmaceuticals, discusses the enrollment in a Phase 1 trial for their lead program which is for the treatment of Ewing Sa...